RAPID MICRO BIOSYSTEMS, INC.
Calidad de datos: 100%
RPID
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
$2.15
▲
$0.02
(0.94%)
Cap. Mercado: 97.75 M
6 months return
—
Momentum
Neutral
5Y revenue growth
9.65%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 9.65% annually over 5 years — modest growth
Debt/Equity of 0.42 — conservative balance sheet
Negative free cash flow of -31.91 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10.09%
Capital efficient — spends only 2.53% of revenue on capex
Price History
Crecimiento
Revenue Growth (5Y)
9.65%
Above sector avg (1.82%)
Revenue (1Y)19.74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-95.32%
Below sector avg (-54.49%)
ROIC-58.94%
Net Margin-140.30%
Op. Margin-141.10%
Seguridad
Debt / Equity
0.42
Above sector avg (0.30)
Current Ratio4.23
Interest Coverage-43.48
Valoración
PE (TTM|NTM)
-2.07 | -2.57
Below sector avg (-1.50)
P/B Ratio2.20
EV/EBITDAN/A
Dividend YieldN/A
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1605 pares)
Comparado con empresas similares en Manufacturing
Comparación con Pares
vs mediana del sector Manufacturing (1605 pares) Comparado con empresas similares en Manufacturing| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -2.1 | -1.5 |
| P/B | 2.2 | 1.6 |
| ROE % | -95.3 | -54.5 |
| Net Margin % | -140.3 | -41.5 |
| Rev Growth 5Y % | 9.7 | 1.8 |
| D/E | 0.4 | 0.3 |
Precio Objetivo de Analistas
3 analistas
Consenso de analistas: objetivo medio vs precio actual y calificación.
Buy
Actual
$2.15
Objetivo
$8.00
$8.00
$8.00
$8.00
Pronóstico
P/E Futuro
-2.57
EPS Futuro
-$0.82
Ingresos Est.
46.45 M
Estimaciones de Ganancias
Pronósticos de EPS e ingresos por período. Anual = años fiscales; trimestral = próximos trimestres.
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
-$0.82
-$0.91 – -$0.74
|
46.45 M | 3 |
| FY2026 |
-$0.92
-$0.96 – -$0.89
|
39.23 M | 3 |
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| 2026 Q2 |
-$0.23
-$0.26 – -$0.20
|
7.68 M | 3 |
| 2026 Q1 |
-$0.25
-$0.28 – -$0.21
|
7.60 M | 3 |
Sorpresas de Ganancias
Últimos 4 trimestres
| Trimestre | EPS Est. | EPS Real | Sorpresa |
|---|---|---|---|
| Q42025 | -$0.23 | -$0.28 | -23.5% |
| Q32025 | -$0.25 | -$0.26 | -6.1% |
| Q22025 | -$0.25 | -$0.27 | -6.6% |
| Q12025 | -$0.27 | -$0.26 | +3.7% |
ETFs Holding This Stock
0.00% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.74% | Revenue Growth (3Y) | 22.13% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9.65% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33.59 M | Net Income (TTM) | -47.12 M |
| ROE | -95.32% | ROA | -58.91% |
| Gross Margin | N/A | Operating Margin | -141.10% |
| Net Margin | -140.30% | Free Cash Flow (TTM) | -31.91 M |
| ROIC | -58.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.42 | Current Ratio | 4.23 |
| Interest Coverage | -43.48 | Asset Turnover | 0.42 |
| Working Capital | 53.40 M | Tangible Book Value | 44.33 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.07 | Forward P/E | -2.57 |
| P/B Ratio | 2.20 | P/S Ratio | 2.91 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2.10 | Fwd Earnings Yield | N/A |
| FCF Yield | -32.65% | ||
| Market Cap | 97.75 M | Enterprise Value | 97.63 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.05 | Revenue / Share | 0.74 |
| FCF / Share | -0.70 | OCF / Share | -0.68 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 2.53% | FCF Conversion | 67.72% |
| SBC-Adj. FCF | -36.25 M | Growth Momentum | 10.09 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 33.59 M | 28.05 M | 22.52 M | 17.13 M | 23.23 M |
| Net Income | -47.12 M | -46.89 M | -52.47 M | -60.81 M | -73.52 M |
| EPS (Diluted) | -1.05 | -1.08 | -1.22 | -1.43 | -3.94 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -47.39 M | -49.92 M | -56.56 M | -63.22 M | -47.23 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 13.60 M | 14.60 M | 12.82 M | 12.87 M | 9.78 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 3.25 M | 3.36 M | 3.11 M | 2.84 M | 1.53 M |
| Interest Expense | 1.09 M | — | 4.21 M | 1.78 M | 2.65 M |
| Income Tax | 40,000.0 | 22,000.0 | 31,000.0 | -576,000.0 | 91,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 74.85 M | 98.17 M | 143.45 M | 190.65 M | 241.17 M |
| Total Liabilities | 41.65 M | 22.82 M | 25.46 M | 26.48 M | 20.19 M |
| Shareholders' Equity | 33.21 M | 75.35 M | 117.99 M | 164.17 M | 220.98 M |
| Total Debt | 18.90 M | — | — | 0.0 | 0.0 |
| Cash & Equivalents | 20.03 M | 16.91 M | 24.29 M | 27.06 M | 178.39 M |
| Current Assets | 61.17 M | 80.92 M | 120.42 M | 138.58 M | 218.12 M |
| Current Liabilities | 18.49 M | 17.57 M | 18.99 M | 19.05 M | 18.17 M |
{"event":"ticker_viewed","properties":{"ticker":"RPID","listing_kind":"stock","pathname":"/stocks/rpid","exchange":"NASDAQ","country":"US"}}